Form 4 for ABT Abbott Laboratories
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-06 · accession 0001415889-25-007453 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-07 | 2025-03-06+ | ABT | Earnhardt Lisa D | EVP AND GROUP Pres | M - OptEx | $80.98 | +91.4K | 72.1K | New | +$7.40M |
| DM | 2025-03-07 | 2025-03-06+ | ABT | Earnhardt Lisa D | EVP AND GROUP Pres | S - Sale+OE | $133.83 | -91.4K | 71.9K | -56% | -$12.23M |
| DM | 2025-03-07 | 2025-03-06+ | ABT | Earnhardt Lisa D | EVP AND GROUP Pres | M - OptEx | $0.00 | -91.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-03-06 | M | A | 91,167 | $80.98 | 163,095 | D | — | — | |
| 2 | Common | Common shares without par value | 2025-03-07 | S | D | 200 | $136.65 | 71,928 | D | — | — | |
| 3 | Common | Common shares without par value | 2025-03-07 | M | A | 200 | $80.98 | 72,128 | D | — | — | |
| 4 | Common | Common shares without par value | 2025-03-06 | S | D | 91,167 | $133.82 | 71,928 | D | — | — | |
| 5 | Derivative | Option (right to buy) | 2025-03-06 | M | D | 91,167 | $0.00 | 200 | D | $80.98 · 2022-06-10 to 2029-06-09 | 91,167 Common shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| 6 | Derivative | Option (right to buy) | 2025-03-07 | M | D | 200 | $0.00 | 0 | D | $80.98 · 2022-06-10 to 2029-06-09 | 200 Common shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |